Vida Ventures Advisors

Latest statistics and disclosures from Vida Ventures Advisors's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Vida Ventures Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Vida Ventures Advisors

Vida Ventures Advisors holds 5 positions in its portfolio as reported in the March 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Kyverna Therapeutics Common Stock 62.4 $112M NEW 4.5M 24.84
 View chart
Centessa Pharmaceuticals Ordinary Shares (CNTA) 24.7 $44M 3.9M 11.30
 View chart
Dyne Therapeutics Common Stock (DYN) 6.4 $12M -80% 408k 28.39
 View chart
Allogene Therapeutics Common Stock (ALLO) 4.5 $8.0M 1.8M 4.47
 View chart
Kronos Bio Common Stock (KRON) 2.0 $3.6M 2.8M 1.30
 View chart

Past Filings by Vida Ventures Advisors

SEC 13F filings are viewable for Vida Ventures Advisors going back to 2020